Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer

on behalf of the International Immuno-Oncology Biomarker Working Group on Breast Cancer

Research output: Contribution to journalReview articlepeer-review

125 Scopus citations

Fingerprint Dive into the research topics of 'Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences